The USFDA defines real-world data (RWD) as ‘the data relating to patient health status and/or the healthcare delivery that is routinely collected from a variety of sources’, and real-world evidence (RWE) as ‘the clinical evidence regarding the usage and potential risks/benefits of a medical product obtained from analysis of RWD.’[1] RWD includes data from electronic […]
There has been a shift in the global healthcare ecosystem from volume-based to value-based payment model, thanks to a surge in data availability, interoperability, advancing health technologies, cost and competitive pressures, scientific advances, and increasing adoption of personalized medicine. The resulting availability of a large quantity of real-world data (RWD) has made it possible to […]
The health and fitness wearable market is on the rise since the last few years. Analysts expect that by 2020, almost half a billion smart wearable devices will have been sold. However, despite the fast-growing market, only 10% of those consumers are using the product daily. This is an opportunity for innovative life science companies […]
Last few years have seen data as well as data exchange emerging as the new currency in healthcare. Data sharing is a powerful force that is transforming conventional relationships in the healthcare marketplace as the global healthcare platform moves from being volume-based to quality-based. (1) Around 30% of the stored global data is generated within […]
Patient Records Abstraction (PRA) is a process done manually by searching through a medical record to identify data required for a particular or secondary use. It consists of direct matching of information found in the record to the data required, but also includes operations on the data such as categorizing, coding, transforming, interpreting, summarizing, and calculating. The […]
Workshop title – “R WE Ready?” – “Real World Evidence” Methods! Organisers – Co-organised by Organisation of Pharmaceutical Producers of India (OPPI) and ISPOR India-Mumbai Chapter Objectives – To enhance skill set of the professionals of the medical affairs community in area of real world evidence generation to […]
We all want safe and effective medicines to reach patients as soon as possible, but as we know, drug development, market authorization and payer assessment are all slow sections of a long and drawn out journey for a drug. But what if patients could have access to medicines not just months earlier, but potentially 8 […]
